The historical paradigm of cataract surgery forced an absolute compromise: pristine distance vision with absolute spectacle ...
Johnson & Johnson (J&J) has received approval from the US Food and Drug Administration (FDA) for its TECNIS PureSee extended depth of focus (EDOF) intraocular lens (IOL), designed for use in cataract ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) is expanding the U.S. roll-out of its latest advancement in presbyopia-correcting intraocular lenses (PC-IOLs). TECNIS PureSee IOL is ...
AUSTIN, TX, UNITED STATES, April 2, 2026 /EINPresswire.com/ — Dell Laser Consultants is proud to be among the first practices in the United States to offer the ...
Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract ...
Johnson & Johnson (JNJ) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its Tecnis PureSee intraocular lens (IOL), giving eye surgeons a new lens option for use in ...
Please provide your email address to receive an email when new articles are posted on . A study compared the Tecnis PureSee extended depth of focus IOL and a Tecnis ...